User profiles for Amos Lal
 | Lal, AmosMayo Clinic Rochester MN Verified email at Mayo.edu Cited by 3136 |
Carbon-based nanomaterials: promising antiviral agents to combat COVID-19 in the microbial-resistant era
Therapeutic options for the highly pathogenic human severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) causing the current pandemic coronavirus disease (COVID-19) …
coronavirus 2 (SARS-CoV-2) causing the current pandemic coronavirus disease (COVID-19) …
[HTML][HTML] Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
Background To date, only dexamethasone and tocilizumab have been shown to reduce
mortality in patients with COVID-19. Baricitinib is a Janus kinase 1/2 inhibitor with known anti-…
mortality in patients with COVID-19. Baricitinib is a Janus kinase 1/2 inhibitor with known anti-…
Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry
… Domecq and Lal helped in drafting the article, acquisition of data, analysis and interpretation
of data, and critical revision of the article. Dr. Sheldrick analyzed and interpreted data. …
of data, and critical revision of the article. Dr. Sheldrick analyzed and interpreted data. …
[HTML][HTML] Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV)
Recently, a new coronavirus disease (COVID-19) has emerged as a respiratory infection with
significant concern for global public health hazards. With an initial suspicion of the animal …
significant concern for global public health hazards. With an initial suspicion of the animal …
COVID-2019: update on epidemiology, disease spread and management
… Sahu KK, Mishra AK, Lal A. Comprehensive update on current outbreak of novel coronavirus
… Mishra AK, Sahu KK, Lal A. Reporting of all cardiac medications and their outcome in …
… Mishra AK, Sahu KK, Lal A. Reporting of all cardiac medications and their outcome in …
[HTML][HTML] Questions concerning the proximal origin of SARS‐CoV‐2
1. SUMMARY There is a consensus that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
originated naturally from bat coronaviruses (CoVs), in particular RaTG13. …
originated naturally from bat coronaviruses (CoVs), in particular RaTG13. …
Organizing pneumonia related to electronic cigarette use: a case report and review of literature
Background and Objective Electronic cigarettes (e cigarettes) are battery operated devices
that produce aerosol by heating a solution typically made up of nicotine, propylene glycol, …
that produce aerosol by heating a solution typically made up of nicotine, propylene glycol, …
A review of cardiac manifestations and predictors of outcome in patients with COVID–19
Coronavirus disease (COVID-19) pandemic has so far involved 184 countries and more than
2.79 million patients worldwide. Over the past three months, it has attributed to more than …
2.79 million patients worldwide. Over the past three months, it has attributed to more than …
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
Although vaccination represents the most promising way to stop or contain the coronavirus
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines were …
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines were …
[HTML][HTML] A unique view of SARS-CoV-2 through the lens of ORF8 protein
Immune evasion is one of the unique characteristics of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) attributed to its ORF8 protein. This protein modulates the …
coronavirus 2 (SARS-CoV-2) attributed to its ORF8 protein. This protein modulates the …